Treatment with bevacizumab and irinotecan in patients with recurrent or refractory high grade glioma after conventional treatment.
Phase of Trial: Phase II
Latest Information Update: 23 May 2014
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 23 May 2014 New trial record